Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement

Charles Welliver*, Randy Sulaver, Adam Whittington, Brian T. Helfand, Ömer Onur çakır, James W Griffith, Kevin T. McVary

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: To determine the motivating factor for why men seek urologic care and determine persistence of these symptoms and any factors that influence resolution. Methods: Men presenting to an outpatient urology clinic with lower urinary tract symptoms (LUTSs) were prospectively evaluated. At each of 2 visits, surveys were administered including the American Urological Association Symptom Index and a chief LUTS complaint (CLC) identification form. On the CLC identification form, symptoms were considered “transient” if only seen at V1 and “persistent” if they were selected at both visits. Results: Sixty-five percent of the 1240 participants were able to specify a CLC. Among these, nocturia was by far the most common and was found to be persistent in 49% of cases. When comparing the groups of patients who presented with transient verses persistent nocturia, older age (P <.001), diabetes (P =.006), hypertension (P =.033), alpha-blocker use (P =.018), 5–alpha-reductase inhibitor use (P =.008), higher nocturia severity (P <.001), and more severe American Urological Association Symptom Index scores at initial visit (P =.047) were found to be predictors of persistent nocturia. Conclusion: Most men with LUTS can identify a predominant CLC. Of these, nocturia is the primary CLC of most men and does not improve in almost 50% of those studied. By improving our identification of a predominant CLC and the patient factors that influence both the development and persistence of urinary symptoms, we may start to better evaluate and hopefully focus treatment on the most bothersome urinary symptom.

Original languageEnglish (US)
Pages (from-to)862-867
Number of pages6
JournalUrology
Volume86
Issue number5
DOIs
StatePublished - Nov 1 2015

Fingerprint

Nocturia
Lower Urinary Tract Symptoms
Nijmegen Breakage Syndrome
Therapeutics
Urology
Ambulatory Care Facilities
Oxidoreductases
Hypertension

ASJC Scopus subject areas

  • Urology

Cite this

Welliver, C., Sulaver, R., Whittington, A., Helfand, B. T., çakır, Ö. O., Griffith, J. W., & McVary, K. T. (2015). Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement. Urology, 86(5), 862-867. https://doi.org/10.1016/j.urology.2015.08.006
Welliver, Charles ; Sulaver, Randy ; Whittington, Adam ; Helfand, Brian T. ; çakır, Ömer Onur ; Griffith, James W ; McVary, Kevin T. / Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement. In: Urology. 2015 ; Vol. 86, No. 5. pp. 862-867.
@article{ab9cf8bda9254c528ee487ce22d7063e,
title = "Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement",
abstract = "Objective: To determine the motivating factor for why men seek urologic care and determine persistence of these symptoms and any factors that influence resolution. Methods: Men presenting to an outpatient urology clinic with lower urinary tract symptoms (LUTSs) were prospectively evaluated. At each of 2 visits, surveys were administered including the American Urological Association Symptom Index and a chief LUTS complaint (CLC) identification form. On the CLC identification form, symptoms were considered “transient” if only seen at V1 and “persistent” if they were selected at both visits. Results: Sixty-five percent of the 1240 participants were able to specify a CLC. Among these, nocturia was by far the most common and was found to be persistent in 49{\%} of cases. When comparing the groups of patients who presented with transient verses persistent nocturia, older age (P <.001), diabetes (P =.006), hypertension (P =.033), alpha-blocker use (P =.018), 5–alpha-reductase inhibitor use (P =.008), higher nocturia severity (P <.001), and more severe American Urological Association Symptom Index scores at initial visit (P =.047) were found to be predictors of persistent nocturia. Conclusion: Most men with LUTS can identify a predominant CLC. Of these, nocturia is the primary CLC of most men and does not improve in almost 50{\%} of those studied. By improving our identification of a predominant CLC and the patient factors that influence both the development and persistence of urinary symptoms, we may start to better evaluate and hopefully focus treatment on the most bothersome urinary symptom.",
author = "Charles Welliver and Randy Sulaver and Adam Whittington and Helfand, {Brian T.} and {\cc}akır, {{\"O}mer Onur} and Griffith, {James W} and McVary, {Kevin T.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.urology.2015.08.006",
language = "English (US)",
volume = "86",
pages = "862--867",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "5",

}

Welliver, C, Sulaver, R, Whittington, A, Helfand, BT, çakır, ÖO, Griffith, JW & McVary, KT 2015, 'Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement', Urology, vol. 86, no. 5, pp. 862-867. https://doi.org/10.1016/j.urology.2015.08.006

Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement. / Welliver, Charles; Sulaver, Randy; Whittington, Adam; Helfand, Brian T.; çakır, Ömer Onur; Griffith, James W; McVary, Kevin T.

In: Urology, Vol. 86, No. 5, 01.11.2015, p. 862-867.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement

AU - Welliver, Charles

AU - Sulaver, Randy

AU - Whittington, Adam

AU - Helfand, Brian T.

AU - çakır, Ömer Onur

AU - Griffith, James W

AU - McVary, Kevin T.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Objective: To determine the motivating factor for why men seek urologic care and determine persistence of these symptoms and any factors that influence resolution. Methods: Men presenting to an outpatient urology clinic with lower urinary tract symptoms (LUTSs) were prospectively evaluated. At each of 2 visits, surveys were administered including the American Urological Association Symptom Index and a chief LUTS complaint (CLC) identification form. On the CLC identification form, symptoms were considered “transient” if only seen at V1 and “persistent” if they were selected at both visits. Results: Sixty-five percent of the 1240 participants were able to specify a CLC. Among these, nocturia was by far the most common and was found to be persistent in 49% of cases. When comparing the groups of patients who presented with transient verses persistent nocturia, older age (P <.001), diabetes (P =.006), hypertension (P =.033), alpha-blocker use (P =.018), 5–alpha-reductase inhibitor use (P =.008), higher nocturia severity (P <.001), and more severe American Urological Association Symptom Index scores at initial visit (P =.047) were found to be predictors of persistent nocturia. Conclusion: Most men with LUTS can identify a predominant CLC. Of these, nocturia is the primary CLC of most men and does not improve in almost 50% of those studied. By improving our identification of a predominant CLC and the patient factors that influence both the development and persistence of urinary symptoms, we may start to better evaluate and hopefully focus treatment on the most bothersome urinary symptom.

AB - Objective: To determine the motivating factor for why men seek urologic care and determine persistence of these symptoms and any factors that influence resolution. Methods: Men presenting to an outpatient urology clinic with lower urinary tract symptoms (LUTSs) were prospectively evaluated. At each of 2 visits, surveys were administered including the American Urological Association Symptom Index and a chief LUTS complaint (CLC) identification form. On the CLC identification form, symptoms were considered “transient” if only seen at V1 and “persistent” if they were selected at both visits. Results: Sixty-five percent of the 1240 participants were able to specify a CLC. Among these, nocturia was by far the most common and was found to be persistent in 49% of cases. When comparing the groups of patients who presented with transient verses persistent nocturia, older age (P <.001), diabetes (P =.006), hypertension (P =.033), alpha-blocker use (P =.018), 5–alpha-reductase inhibitor use (P =.008), higher nocturia severity (P <.001), and more severe American Urological Association Symptom Index scores at initial visit (P =.047) were found to be predictors of persistent nocturia. Conclusion: Most men with LUTS can identify a predominant CLC. Of these, nocturia is the primary CLC of most men and does not improve in almost 50% of those studied. By improving our identification of a predominant CLC and the patient factors that influence both the development and persistence of urinary symptoms, we may start to better evaluate and hopefully focus treatment on the most bothersome urinary symptom.

UR - http://www.scopus.com/inward/record.url?scp=85027932467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027932467&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2015.08.006

DO - 10.1016/j.urology.2015.08.006

M3 - Article

VL - 86

SP - 862

EP - 867

JO - Urology

JF - Urology

SN - 0090-4295

IS - 5

ER -